Howard Berger'un ücretlendirmesi RadNet'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2025	n/a	n/a	-US$13m
Jun 30 2025	n/a	n/a	-US$15m
Mar 31 2025	n/a	n/a	-US$32m
Dec 31 2024	US$9m	US$3m	US$3m
Sep 30 2024	n/a	n/a	-US$4m
Jun 30 2024	n/a	n/a	US$10m
Mar 31 2024	n/a	n/a	US$21m
Dec 31 2023	US$7m	US$2m	US$3m
Sep 30 2023	n/a	n/a	US$4m
Jun 30 2023	n/a	n/a	-US$13m
Mar 31 2023	n/a	n/a	-US$13m
Dec 31 2022	US$6m	US$2m	US$11m
Sep 30 2022	n/a	n/a	US$8m
Jun 30 2022	n/a	n/a	US$23m
Mar 31 2022	n/a	n/a	US$18m
Dec 31 2021	US$5m	US$1m	US$25m
Sep 30 2021	n/a	n/a	US$35m
Jun 30 2021	n/a	n/a	US$24m
Mar 31 2021	n/a	n/a	US$11m
Dec 31 2020	US$3m	US$783k	-US$15m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	-US$13m
Mar 31 2020	n/a	n/a	US$2m
Dec 31 2019	US$3m	US$1m	US$15m

Tazminat ve Piyasa: Howard 'ın toplam tazminatı ($USD 9.08M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 8.15M ).

Tazminat ve Kazançlar: Howard şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Howard Berger (79 yo)

39yrs

Görev süresi

US$9,076,437

Tazminat

Dr. Howard G. Berger, M.D., serves as the President and Chief Financial Officer of Image Medical Corporation. Dr. Berger has been the Chief Executive Officer and President at RadNet, Inc. and its predecess...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Howard Berger	Chairman	39yrs	US$9.08m	0.42% $ 24.3m
Mark Stolper	Executive VP & CFO	21.5yrs	US$1.88m	0.13% $ 7.7m
A. Sorensen	Executive VP	2.4yrs	US$1.33m	1.51% $ 86.4m
Norman Hames	President & COO of Western Operations	no data	US$2.14m	0.31% $ 17.9m
Stephen Forthuber	President & COO of Eastern Operations	8.7yrs	US$2.15m	0.67% $ 38.6m
Cornelis Wesdorp	President & CEO of Digital Health	1.3yrs	US$4.79m	0.069% $ 4.0m
Susan Hollabaugh	Chief Information Officer	less than a year	Veri yok	Veri yok
Mital Patel	Executive VP of Financial Planning & Analysis and Chief Administrative Officer	5yrs	US$1.92m	0.23% $ 13.3m
Laura Foster	Senior Vice President of Compliance & Regulatory Affairs	8.8yrs	Veri yok	Veri yok
David Katz	Executive VP	5.8yrs	Veri yok	0.093% $ 5.3m
Michael Murdock	Executive Vice President of Mergers & Acquisitions	19yrs	Veri yok	0.052% $ 3.0m
Ranjan Jayanathan	Executive VP & GM of eRAD - Radiology Information Technology Division	less than a year	Veri yok	0.18% $ 10.3m

5.8yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim: RDNT 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Howard Berger	Chairman	34yrs	US$9.08m	0.42% $ 24.3m
A. Sorensen	Executive VP	2.4yrs	US$1.33m	1.51% $ 86.4m
David Swartz	Lead Independent Director	22yrs	US$297.99k	0.28% $ 15.9m
Gregory Spurlock	Independent Director	4.6yrs	US$246.99k	0.0069% $ 392.6k
Lawrence Levitt	Independent Director	21yrs	US$266.74k	0.21% $ 12.2m
Laura Jacobs	Independent Director	6yrs	US$262.99k	0.035% $ 2.0m

13.5yrs

Ortalama Görev Süresi

73.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: RDNT 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 13.5 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2026/01/06 10:17
Gün Sonu Hisse Fiyatı	2026/01/05 00:00
Kazançlar	2025/09/30
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

RadNet, Inc. 11 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Sarah James	Barclays
Andrew Mok	Barclays
Yuan Zhi	B. Riley Securities, Inc.

RadNet Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

RadNet, Inc., Annual General Meeting, Jun 10, 2025

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

Recent updates

RadNet, Inc. and DeepHealth, Inc. Announces Results from the Real-World Analysis of AI-Driven Breast Cancer Screening Ever Conducted in the United States

Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts

RadNet, Inc. Updates Earnings Guidance for the Full Year 2025

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

RadNet: Bloated Capital Base Not Pulling Its Economic Weight (Rating Downgrade)

RadNet, Inc. Updates Earnings Guidance for the Full Year 2025

Some Confidence Is Lacking In RadNet, Inc.'s (NASDAQ:RDNT) P/S

RadNet (NASDAQ:RDNT) May Have Issues Allocating Its Capital

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is There An Opportunity With RadNet, Inc.'s (NASDAQ:RDNT) 37% Undervaluation?

RadNet, Inc., Annual General Meeting, Jun 10, 2025

Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?

RadNet, Inc. (NasdaqGM:RDNT) entered into an Agreement and Plan of Merger to acquire iCAD, Inc. (NasdaqCM:ICAD) for approximately $100 million.

Returns On Capital Signal Tricky Times Ahead For RadNet (NASDAQ:RDNT)

RadNet: On The Sidelines For Now

RadNet, Inc. Provides Financial Guidance for the Fiscal Year 2025

There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Price

A Look At The Fair Value Of RadNet, Inc. (NASDAQ:RDNT)

Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?

RadNet, Inc. Revises Earnings Guidance for the Year 2024

RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

Expanding Imaging Modalities And AI Integration Signal Strong Future Growth In Healthcare Sector

RadNet: Growth In Operating Earnings Off Very Little Incremental Capital

RadNet: Qualified Growth Route, Still Undervalued

Price target increased by 7.2% to US$57.17

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 23% overvalued after recent price rise

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

Price target increased by 12% to US$45.80

Now 21% overvalued after recent price rise

Full year 2023 earnings: EPS misses analyst expectations

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

Radnet, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Announces Appointment of Executives

Consensus EPS estimates upgraded to US$0.10 loss

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold US$1.4m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

President & COO of Western Operations exercised options to buy US$1.5m worth of stock.

RadNet, Inc., Annual General Meeting, Jun 07, 2023

Board Member recently sold US$138k worth of stock

RadNet, Inc. Revises Earnings Guidance for the Year 2023

Price target increased by 7.8% to US$34.50

President & COO of Eastern Operations recently sold US$230k worth of stock

Insider recently sold US$443k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold US$97k worth of stock

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

Investor sentiment deteriorated over the past week

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Price target decreased to US$32.25

Investor sentiment improved over the past week

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha